Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison Between iLux and LipiFlow in the Treatment of Meibomian Gland Dysfunction (MGD): A 12-month, Multicenter Study

NCT03956225 is registered in ClinicalTrials.gov with Alcon Research as lead sponsor.

NCT NCT03956225
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03956225 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison Between iLux and LipiFlow in the Treatment of Meibomian Gland Dysfunction (MGD): A 12-month, Multicenter Study
Lead sponsor
Alcon Research
Phase
Not applicable
Overall status
Completed
Start date
June 25, 2019
Completion date
October 24, 2020
Enrollment
299 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

evaporative dry eye disease, meibomian gland dysfunction